MedTrace Logo

Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk

NCT03000803 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-01-12

No results posted yet for this study

Summary

The purpose of this study is to examine how the timing of eating changes 24hr profiles of lipids involved in eating for pleasure and how the body makes and uses energy (metabolism).

Conditions

Interventions

BEHAVIORAL

Early Total Caloric Intake

Provide subjects a regimented amount of calories at each meal.

BEHAVIORAL

Late Total Caloric Intake

Provide subjects a regimented amount of calories at each meal.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Erin Hanlon, PhD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2029-10-31
Completion
2029-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03000803 on ClinicalTrials.gov